Decreased IL-1ra and NCAM-1/CD56 Serum Levels in Unmedicated Patients with Schizophrenia Before and After Antipsychotic Treatment
Che-Sheng Chu, Dian-Jeng Li, Chin-Liang Chu, Chih-Ching Wu, Ti Lu
Psychiatry Investig. 2018;15(7):727-732.   Published online 2018 Jun 15     DOI: https://doi.org/10.30773/pi.2017.11.10
Association between C-reactive protein levels and antipsychotic treatment during 12 months follow-up period after acute psychosis
Farivar Fathian, Rolf Gjestad, Rune A. Kroken, Else-Marie Løberg, Solveig Klæbo Reitan, W. Wolfgang Fleichhacker, Maria Rettenbacher, Tor K. Larsen, Inge Joa, Lena Antonsen Stabell, Eirik Kjelby, Igne Sinkevicute, Renata Alisauskiene, Vidar M. Steen, Erik
Schizophrenia Research.2022; 241: 174.     CrossRef
Distinct Inflammation Biomarkers in Healthy Individuals and Patients with Schizophrenia: A Reliability Testing of Multiplex Cytokine Immunoassay by Bland-Altman Analysis
Ta-Chuan Yeh, Hsuan-Te Chu, Chia-Kuang Tsai, Hsin-An Chang, Fu-Chi Yang, San-Yuan Huang, Chih-Sung Liang
Psychiatry Investigation.2019; 16(8): 607.     CrossRef
Cytokine Alterations in Schizophrenia: An Updated Review
Sara Momtazmanesh, Ameneh Zare-Shahabadi, Nima Rezaei
Frontiers in Psychiatry.2019;[Epub]     CrossRef